Myeloma Paper of the Day, November 7th, Suggested by Robert Orlowski

Coverage, in order

1. 5d ago
   
   first OncoDaily obscure study

   Myeloma Paper of the Day, November 7th, Suggested by Robert Orlowski

   Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X: “Myeloma Paper of the Day: Home grown autologous fully-human 3rd-generation CD20-directed CAR-T

2. 4d ago
   
   OncoDaily obscure study

   Myeloma Paper of the Day, November 7th, Suggested by Robert Orlowski

   Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X: “Myeloma Paper of the Day: Dara-VRd, upfront ASCT and len maintenance for

3. 3d ago
   
   OncoDaily obscure study

   Myeloma Paper of the Day, November 9th, Suggested by Robert Orlowski

   Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X: “Myeloma Paper of the Day: Patients w/ #amyloidosis & implanted cardioverter defibrillators

4. 2d ago
   
   OncoDaily obscure study

   Myeloma Paper of the Day, November 10th, Suggested by Robert Orlowski

   Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X: “Myeloma Paper of the Day: Modeling of long-term PFS in NDMM treated

5. 1d ago
   
   OncoDaily obscure study

   Myeloma Paper of the Day, November 11th, Suggested by Robert Orlowski

   Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X: “Myeloma Paper of the Day: A commercial claims analysis looking at 12-month

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.